Evidence map›Paper›PMID 32662773›Full record

ArticleeLife2020

Flotillin-mediated membrane fluidity controls peptidoglycan synthesis and MreB movement.

Aleksandra Zielińska, Abigail Savietto, Anabela de Sousa Borges, Denis Martinez, Melanie Berbon, Joël R Roelofsen, Alwin M Hartman, Rinse de Boer, Ida J Van der Klei, Anna Kh Hirsch and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. α-Terpineol reversesFrontiers in cellular and infection microbiology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bacterial lipid biophysics and membrane organization.Current opinion in microbiology · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Aleksandra Zielińska *Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.
Abigail Savietto *Biozentrum, Ludwig-Maximilians-Universität München, München, Germany.
Anabela de Sousa BorgesMolecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.
Denis MartinezInstitute of Chemistry & Biology of Membranes & Nanoobjects (UMR5248 CBMN), IECB, CNRS, Université Bordeaux, Institut Polytechnique Bordeaux, Pessac, France.
Melanie BerbonInstitute of Chemistry & Biology of Membranes & Nanoobjects (UMR5248 CBMN), IECB, CNRS, Université Bordeaux, Institut Polytechnique Bordeaux, Pessac, France.
Joël R RoelofsenMolecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.
Alwin M HartmanDepartment of Drug Design and Optimization (DDOP), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Rinse de BoerMolecular Cell Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.
Ida J Van der KleiMolecular Cell Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.ORCID 0000-0001-7165-9679
Anna Kh HirschDepartment of Drug Design and Optimization (DDOP), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Birgit HabensteinInstitute of Chemistry & Biology of Membranes & Nanoobjects (UMR5248 CBMN), IECB, CNRS, Université Bordeaux, Institut Polytechnique Bordeaux, Pessac, France.
Marc BramkampBiozentrum, Ludwig-Maximilians-Universität München, München, Germany.ORCID 0000-0002-7704-3266
Dirk-Jan ScheffersMolecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.ORCID 0000-0002-9439-9168
University of Groningen · NLCentre National de la Recherche Scientifique · FRChristian-Albrechts-Universität zu Kiel · DE

Funding

Deutsche Forschungsgemeinschaft BR 2915/7-1Deutsche Forschungsgemeinschaft INST 86/1452-1Deutscher Akademischer Austauschdienst PhD fellowship DAAD-GSSPEuropean Research Council starting grant 757913Fundação para a Ciência e a Tecnologia PhD fellowship SFRH/BD/78061/2011- POPH/FSE/FCTNederlandse Organisatie voor Wetenschappelijk Onderzoek 721.014.008Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi 864.09.010
6 · The paper itself

Abstract

The bacterial plasma membrane is an important cellular compartment. In recent years it has become obvious that protein complexes and lipids are not uniformly distributed within membranes. Current hypotheses suggest that flotillin proteins are required for the formation of complexes of membrane proteins including cell-wall synthetic proteins. We show here that bacterial flotillins are important factors for membrane fluidity homeostasis. Loss of flotillins leads to a decrease in membrane fluidity that in turn leads to alterations in MreB dynamics and, as a consequence, in peptidoglycan synthesis. These alterations are reverted when membrane fluidity is restored by a chemical fluidizer. In vitro, the addition of a flotillin increases membrane fluidity of liposomes. Our data support a model in which flotillins are required for direct control of membrane fluidity rather than for the formation of protein complexes via direct protein-protein interactions.

Indexed as

Bacillus subtilisBacterial ProteinsMembrane FluidityMembrane ProteinsPeptidoglycanBacterial ProteinsflotillinsMembrane ProteinsPeptidoglycanbacteriaB. subtiliscell biologyfunctional membrane microdomaininfectious diseaselipid raftsmembrane organisationmicrobiologypenicillin binding protein

Identifiers

PMID32662773
PMCPMC7360373
OpenAlexW3042611656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.